4.3 Article

Critical Interactions Between the Global Fund-Supported HIV Programs and the Health System in Ghana

Journal

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/QAI.0b013e318221842a

Keywords

AIDS; HIV; health systems; horizontal; integration; vertical

Ask authors/readers for more resources

The support of global health initiatives in recipient countries has been vigorously debated. Critics are concerned that disease-specific programs may be creating vertical and parallel service delivery structures that to some extent undermine health systems. This case study of Ghana aimed to explore how the Global Fund-supported HIV program interacts with the health system there and to map the extent and nature of integration of the national disease program across 6 key health systems functions. Qualitative interviews of national stakeholders were conducted to understand the perceptions of the strengths and weaknesses of the relationship between Global Fund-supported activities and the health system and to identify positive synergies and unintended consequences of integration. Ghana has a well-functioning sector-wide approach to financing its health system, with a strong emphasis on integrated care delivery. Ghana has benefited from US $175 million of approved Global Fund support to address the HIV epidemic, accounting for almost 85% of the National AIDS Control Program budget. Investments in infrastructure, human resources, and commodities have enabled HIV interventions to increase exponentially. Global Fund-supported activities have been well integrated into key health system functions to strengthen them, especially financing, planning, service delivery, and demand generation. Yet, with governance and monitoring and evaluation functions, parallel structures to national systems have emerged, leading to inefficiencies. This case study demonstrates that interactions and integration are highly varied across different health system functions, and strong government leadership has facilitated the integration of Global Fund-supported activities within national programs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Gastroenterology & Hepatology

Healthcare and socioeconomic costs of NAFLD: A global framework to navigate the uncertainties

Alina M. Allen, Jeffrey Lazarus, Zobair M. Younossi

Summary: Non-alcoholic fatty liver disease (NAFLD) has significant health, economic and social implications, requiring a shift in conceptualization and collaborative action to address the public health threat. The healthcare costs of NAFLD patients are nearly double compared to those without the disease, with the highest costs in advanced fibrosis and end-stage liver disease. NAFLD accounts for the highest increase in disability-adjusted life years (DALYs) among all liver diseases globally. Currently, there are no specific drug therapies for NAFLD and non-alcoholic steatohepatitis (NASH), with uncertainties surrounding cost, treatment duration, and their impact on liver-related outcomes and mortality.

JOURNAL OF HEPATOLOGY (2023)

Letter Gastroenterology & Hepatology

A call for the comprehensive diagnosis of viral hepatitis as a key step towards its elimination

Javier Crespo, Jose Luis Calleja, Joaquin Cabezas, Federico Garcia, Antonio Aguilera, Francisco Jorquera, Jeffrey V. V. Lazarus

LIVER INTERNATIONAL (2023)

Article Gastroenterology & Hepatology

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Sven M. Francque, Arun J. Sanyal, Fasiha Kanwal, Diana Romero, Manal F. Abdelmalek, Quentin M. Anstee, Juan Pablo Arab, Marco Arrese, Ramon Bataller, Ulrich Beuers, Jerome Boursier, Elisabetta Bugianesi, Christopher D. Byrne, Graciela E. Castro Narro, Abhijit Chowdhury, Helena Cortez-Pinto, Donna R. Cryer, Kenneth Cusi, Mohamed El-Kassas, Samuel Klein, Wayne Eskridge, Jiangao Fan, Samer Gawrieh, Cynthia D. Guy, Stephen A. Harrison, Seung Up Kim, Bart G. Koot, Marko Korenjak, Kris V. Kowdley, Florence Lacaille, Rohit Loomba, Robert Mitchell-Thain, Timothy R. Morgan, Elisabeth E. Powell, Michael Roden, Manuel Romero-Gomez, Marcelo Silva, Shivaram Prasad Singh, Silvia C. Sookoian, C. Wendy Spearman, Dina Tiniakos, Luca Valenti, Miriam B. Vos, Vincent Wai-Sun Wong, Stavra Xanthakos, Yusuf Yilmaz, Zobair Younossi, Ansley Hobbs, Marcela Villota-Rivas, Philip N. Newsome

Summary: This study aimed to determine if there was a need to change the nomenclature and definition of NAFLD and NASH. Through a Delphi process involving content experts and patient advocates, a consensus was reached to replace NAFLD with metabolic dysfunction-associated steatotic liver disease (MetALD) and modify the diagnostic criteria. The new nomenclature and criteria are widely supported, nonstigmatizing, and can improve awareness and patient identification.

HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

The global fatty liver disease Sustainable Development Goal country score for 195 countries and territories

Jeffrey Lazarus, Hannah Han, Henry E. Mark, Saleh A. Alqahtani, Joern M. Schattenberg, Joan B. Soriano, Trenton M. White, Shira Zelber-Sagi, M. Ashworth Dirac

Summary: This study developed a fatty liver disease Sustainable Development Goal (SDG) country score to assess country-level preparedness. The findings showed variations in fatty liver disease-SDG scores among countries and regions, with the highest score in the high-income super-region and the lowest score in South Asia. The fatty liver disease-SDG score increased in all super-regions between 1990 and 2017. Therefore, this score serves as a strategic advocacy tool for liver health and noncommunicable disease advocates to address fatty liver disease and overall noncommunicable diseases.

HEPATOLOGY (2023)

Editorial Material Gastroenterology & Hepatology

It is time to expand the fatty liver disease community of practice

Jeffrey V. Lazarus, Christopher J. Kopka, Zobair M. Younossi, Alina M. Allen

HEPATOLOGY (2023)

Review Immunology

Uncovering the NAFLD burden in people living with HIV from high- and middle-income nations: a meta-analysis with a data gap from Subsaharan Africa

Ramiro Manzano-Nunez, Jesus Rivera-Esteban, Jordi Navarro, Juan Banares, Elena Sena, Joern M. Schattenberg, Jeffrey Lazarus, Adria Curran, Juan M. Pericas

Summary: This systematic review and meta-analysis investigated the prevalence of non-alcoholic fatty liver disease (NAFLD) and significant fibrosis in people living with HIV (PLHIV). The study found that the prevalence of NAFLD in PLHIV was 38%, and the prevalence of significant fibrosis was 13%. Higher body mass index, triglyceride levels, and dyslipidemia were associated with a higher risk of NAFLD among PLHIV.

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2023)

Letter Gastroenterology & Hepatology

Reply: NAFLD, MAFLD, or MASLD? Cut the Gordian knot with Ludwig disease

Philip Newsome, Mary E. Rinella, Jeffrey V. Lazarus, Norah Terrault

HEPATOLOGY (2023)

Article Infectious Diseases

Prevalence and sociodemographic determinants of public stigma towards people with HIV and its impact on HIV testing uptake: A cross-sectional study in 64 low- and middle-income countries

Ana Mendez-Lopez, Trenton M. White, Maria Jose Fuster-RuizdeApodaca, Jeffrey V. Lazarus

Summary: A study found that HIV stigma and discrimination contribute to adverse HIV outcomes by discouraging engagement in HIV care. The prevalence of public stigma towards people with HIV was measured across 64 low- and middle-income countries. Results showed that stigma varied widely among countries and was associated with lower testing uptake.

HIV MEDICINE (2023)

Editorial Material Immunology

A people-centred health system must be the foundation for person-centred care in the HIV response

Jeffrey V. Lazarus, Rena Janamnuaysook, Georgina Caswell

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2023)

Article Immunology

A person-centred approach to enhance the long-term health and wellbeing of people living with HIV in Europe

Jeffrey V. V. Lazarus, Mario Cascio, Jane Anderson, Sini Pasanen, Richard Harding

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2023)

Article Medicine, Research & Experimental

Combined COVID-19 vaccination and hepatitis C virus screening intervention in marginalised populations in Spain

Jeffrey V. Lazarus, Marcela Villota-Rivas, Pablo Ryan, Maria Buti, Lara Grau-Lopez, Guillermo Cuevas, Jose Luis Espada, William Moron, Raul Felipe Palma-Alvarez, Jordan J. Feld, Jorge Valencia

Summary: This study assessed the acceptability of combining HCV testing with COVID-19 vaccination in marginalised groups in Spain. The majority of participants were willing to receive both the COVID-19 vaccine and HCV testing, suggesting that this approach could be effective in reaching and providing healthcare services to marginalised populations.

COMMUNICATIONS MEDICINE (2023)

Article Gastroenterology & Hepatology

Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liver

Javier Crespo, Joaquin Cabezas, Antonio Aguilera, Agustin Albillos, Maria Buti, Jose Luis Calleja, Jorge Calvo Montes, Marta Casado Martin, Moises Diago, Conrado M. Fernandez Rodriguez, Inmaculada Fernandez Vazquez, Xavier Forns, Federico Garcia, Javier Garcia-Samaniego, Manuel Hernandez-Guerra de Aguilar, Francisco Jorquera, Jeffrey Lazarus, Sabela Lens, Elisa Martro, Jose Maria Molero Garcia, Maria Jose Pena Lopez, Juan Antonio Pineda, Manuel Rodriguez, Manuel Romero-Gomez, Gloria Sanchez Antolin, Miguel A. Serra Desfilis, Juan Turnes

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS (2023)

Article Medicine, Research & Experimental

Community-based screening enhances hepatitis B virus linkage to care among West African migrants in Spain

Camila A. Picchio, Daniel K. Nomah, Ariadna Rando-Segura, Maria Buti, Sabela Lens, Xavier Forns, Sergio Rodriguez Tajes, Emma Fernandez, Javier Pamplona Portero, Carmen Lopez Nunez, Lena van Selm, Marina Mackinnon, Silvia G. Araujo, Elisa Martro, Francisco Rodriguez-Frias, Jeffrey V. Lazarus

Summary: This community-based HBV screening program provides a successful model for identifying and providing care, including vaccination, to west African migrants at high risk of HBV infection who may otherwise not engage in care.

COMMUNICATIONS MEDICINE (2023)

Article Medicine, Research & Experimental

Integrating social nutrition principles into the treatment of steatotic liver disease

Dana Ivancovsky-Wajcman, Paul N. Brennan, Christopher J. Kopka, Shira Zelber-Sagi, Zobair M. Younossi, Alina M. Allen, Karen R. Florez, Jeffrey V. Lazarus

Summary: This article suggests adopting a holistic preventive hepatology approach, including social nutrition and social prescribing, to address metabolic dysfunction-associated steatotic liver disease. This approach aims to facilitate individuals' engagement in behavioral modifications.

COMMUNICATIONS MEDICINE (2023)

Article Medicine, General & Internal

Integrated management of HIV, diabetes, and hypertension in sub-Saharan Africa (INTE-AFRICA): a pragmatic clusterrandomised, controlled trial

Sokoine Kivuyo, Josephine Birungi, Joseph Okebe, Duolao Wang, Kaushik Ramaiya, Samafilan Ainan, Faith Tumuhairwe, Simple Ouma, Ivan Namakoola, Anupam Garrib, Erik van Widenfelt, Gerald Mutungi, Gerard Abou Jaoude, Neha Batura, Joshua Musinguzi, Mina Nakawuka Ssali, Bernard Michael Etukoit, Kenneth Mugisha, Meshack Shimwela, Omary Said Ubuguyu, Abel Makubi, Caroline Jeffery, Stephen Watiti, Jolene Skordis, Luis Cuevas, Nelson K. Sewankambo, Geoff Gill, Anne Katahoire, Peter G. Smith, Max Bachmann, Jeffrey V. Lazarus, Sayoki Mfinanga, Moffat J. Nyirenda, Shabbar Jaffar

Summary: Integrated management of chronic conditions can improve care for patients with diabetes or hypertension without adversely affecting outcomes for HIV patients in sub-Saharan Africa.

LANCET (2023)

No Data Available